Efficacy of an Oral Formula in Prevention of Anti-Cancer Therapy Side Effects - Full Text View

Efficacy of an Oral Formula in Prevention of Anti-Cancer Therapy Side Effects

This study is currently recruiting participants.
Verified by Nestle Clinical Nutrition, April 2008

Sponsored by:	Nestle Clinical Nutrition
Information provided by:	Nestle Clinical Nutrition
ClinicalTrials.gov Identifier:	NCT00455247

Purpose

Anti-cancer treatment is often inducing side-effects that can affect the compliance to the treatment protocol and quality of life of the patients. The researchers will study if the nutritional intervention with the product could abrogate the undesired effects in a preventive manner.

Condition	Intervention	Phase
Digestive Cancers	Drug: Glutamine	Phase III

MedlinePlus related topics:

Cancer

Drug Information available for:

Glutamine

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Prevention, Randomized, Double-Blind, Placebo Control, Parallel Assignment

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

Patient with GI neoplasm
Newly diagnosed cancer patient that should undergo anti-cancer treatment or patient that should undergo a new anti-cancer treatment
Age > 18 ans
Orally fed
Having obtained his/her informed consent
Life expectancy more than 3 months

Exclusion Criteria:

Positive HIV status
Pregnant or lactating woman
Currently participating or having participated in another clinical trial during the last prior 1 month to the beginning of this study
Patient regularly having diarrhoea before inclusion
State of sub occlusion, chronic inflammatory diseases of the digestive tract, radiation enteropathy
Sepsis

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00455247

Contacts


Contact: Pierre SENESSE, MD	+33 4 67 61 85 54	psenesse@valdorel.fnclcc.fr

Locations


France
	CRLC Val d'Aurelle	Recruiting
	Montpellier, France, 34090
	CRLCC Léon Bérard	Recruiting
	Lyon, France, 69008
	CHU Charles Nicolle	Not yet recruiting
	Rouen, France, 76000

Sponsors and Collaborators

Nestle Clinical Nutrition

Investigators


Principal Investigator:	Pierre SENESSE, MD	CRLC Val d'Aurelle

More Information

Study ID Numbers:	06.23.CLI
First Received:	March 1, 2007
Last Updated:	April 28, 2008
ClinicalTrials.gov Identifier:	NCT00455247
Health Authority:	France: Ministry of Health

ClinicalTrials.gov processed this record on October 22, 2008